William F. Rencher - 19 Oct 2021 Form 3/A - Amendment Insider Report for Context Therapeutics Inc. (CNTX)

Role
Head of CMC and Regulatory
Signature
/s/ Alex Levit, Attorney-in-Fact
Issuer symbol
CNTX
Transactions as of
19 Oct 2021
Net transactions value
$0
Form type
3/A - Amendment
Filing time
17 Dec 2021, 15:08:46 UTC
Date Of Original Report
19 Oct 2021
Next filing
17 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CNTX Stock Option (right to buy) 19 Oct 2021 Common Stock 416 $20.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested

Remarks:

These additional options were omitted from the reporting person's original Form 3 on October 19, 2021.